Cross Country Healthcare Toekomstige groei
Future criteriumcontroles 3/6
De omzet van Cross Country Healthcare zal naar verwachting dalen met 5.3% per jaar, terwijl de jaarlijkse winst naar verwachting zal groeien met 119.4% per jaar. De winst per aandeel zal naar verwachting groeien met 113.3% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 4.2% zijn.
Belangrijke informatie
119.4%
Groei van de winst
113.3%
Groei van de winst per aandeel
| Healthcare winstgroei | 20.8% |
| Inkomstengroei | -5.3% |
| Toekomstig rendement op eigen vermogen | 4.2% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 12 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
Cross Country Healthcare: The Strong Balance Sheet Provides A Sufficient Margin Of Safety
Oct 15Cross Country Healthcare, Inc.'s (NASDAQ:CCRN) Shares Bounce 30% But Its Business Still Trails The Market
Jul 31
Benign Growth For Cross Country Healthcare, Inc. (NASDAQ:CCRN) Underpins Stock's 25% Plummet
Feb 22Calculating The Intrinsic Value Of Cross Country Healthcare, Inc. (NASDAQ:CCRN)
Feb 09Cross Country Healthcare (NASDAQ:CCRN) Is Achieving High Returns On Its Capital
Oct 09Should You Investigate Cross Country Healthcare, Inc. (NASDAQ:CCRN) At US$23.23?
Sep 13These 4 Measures Indicate That Cross Country Healthcare (NASDAQ:CCRN) Is Using Debt Reasonably Well
Aug 19Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)
Jun 26At US$27.39, Is It Time To Put Cross Country Healthcare, Inc. (NASDAQ:CCRN) On Your Watch List?
Jun 08Is Cross Country Healthcare (NASDAQ:CCRN) Using Too Much Debt?
Apr 28Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)
Mar 15Why Cross Country Healthcare, Inc. (NASDAQ:CCRN) Could Be Worth Watching
Mar 02If EPS Growth Is Important To You, Cross Country Healthcare (NASDAQ:CCRN) Presents An Opportunity
Jan 20Cross Country Healthcare (NASDAQ:CCRN) Has A Rock Solid Balance Sheet
Jan 05Is Now The Time To Look At Buying Cross Country Healthcare, Inc. (NASDAQ:CCRN)?
Oct 29Investors Shouldn't Overlook Cross Country Healthcare's (NASDAQ:CCRN) Impressive Returns On Capital
Oct 14Paring My Cross Country Healthcare Gains
Sep 29Should You Be Adding Cross Country Healthcare (NASDAQ:CCRN) To Your Watchlist Today?
Sep 26Cross Country Healthcare to acquire assets of Mint Medical Physician Staffing, LP and Lotus Medical Staffing LLC
Sep 14Cross Country Healthcare (NASDAQ:CCRN) Has A Pretty Healthy Balance Sheet
Aug 21Cross Country Healthcare rises postmarket on $100M stock buyback program
Aug 16Cross Country Healthcare Q2 Non-GAAP EPS, revenue beats, Q3 guidance provided
Aug 03Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 1,294 | 23 | N/A | N/A | 4 |
| 12/31/2025 | 1,265 | 19 | 42 | 49 | 8 |
| 12/31/2024 | 1,341 | -7 | 97 | 105 | 8 |
| 9/30/2024 | 1,448 | -2 | 99 | 108 | N/A |
| 6/30/2024 | 1,575 | 8 | 159 | 171 | N/A |
| 3/31/2024 | 1,776 | 46 | 195 | 208 | N/A |
| 12/31/2023 | 2,020 | 73 | 235 | 248 | N/A |
| 9/30/2023 | 2,234 | 102 | 228 | 241 | N/A |
| 6/30/2023 | 2,428 | 124 | 298 | 311 | N/A |
| 3/31/2023 | 2,641 | 156 | 200 | 210 | N/A |
| 12/31/2022 | 2,807 | 188 | 125 | 134 | N/A |
| 9/30/2022 | 2,819 | 227 | 47 | 56 | N/A |
| 6/30/2022 | 2,558 | 216 | -95 | -87 | N/A |
| 3/31/2022 | 2,136 | 175 | -98 | -90 | N/A |
| 12/31/2021 | 1,677 | 132 | -93 | -86 | N/A |
| 9/30/2021 | 1,252 | 59 | -16 | -10 | N/A |
| 6/30/2021 | 1,071 | 34 | -21 | -16 | N/A |
| 3/31/2021 | 956 | 9 | -20 | -15 | N/A |
| 12/31/2020 | 836 | -13 | 23 | 27 | N/A |
| 9/30/2020 | 836 | -19 | 15 | 20 | N/A |
| 6/30/2020 | 851 | -21 | 10 | 14 | N/A |
| 3/31/2020 | 837 | -58 | 7 | 10 | N/A |
| 12/31/2019 | 822 | -58 | 3 | 6 | N/A |
| 9/30/2019 | 808 | -76 | 7 | 10 | N/A |
| 6/30/2019 | 800 | -74 | 24 | 28 | N/A |
| 3/31/2019 | 801 | -20 | 16 | 21 | N/A |
| 12/31/2018 | 816 | -17 | 16 | 21 | N/A |
| 9/30/2018 | 835 | 31 | 34 | 39 | N/A |
| 6/30/2018 | 863 | 38 | N/A | 38 | N/A |
| 3/31/2018 | 868 | 41 | N/A | 57 | N/A |
| 12/31/2017 | 865 | 38 | N/A | 46 | N/A |
| 9/30/2017 | 868 | 2 | N/A | 27 | N/A |
| 6/30/2017 | 854 | 9 | N/A | 43 | N/A |
| 3/31/2017 | 845 | -13 | N/A | 29 | N/A |
| 12/31/2016 | 834 | 8 | N/A | 30 | N/A |
| 9/30/2016 | 804 | 10 | N/A | 32 | N/A |
| 6/30/2016 | 785 | 1 | N/A | 25 | N/A |
| 3/31/2016 | 778 | 21 | N/A | 21 | N/A |
| 12/31/2015 | 767 | 4 | N/A | 18 | N/A |
| 9/30/2015 | 762 | -10 | N/A | 18 | N/A |
| 6/30/2015 | 756 | -22 | N/A | 7 | N/A |
| 3/31/2015 | 686 | -28 | N/A | 5 | N/A |
| 12/31/2014 | 618 | -32 | N/A | -4 | N/A |
| 9/30/2014 | 539 | -64 | N/A | -6 | N/A |
| 6/30/2014 | 458 | -55 | N/A | -1 | N/A |
| 3/31/2014 | 446 | -54 | N/A | 1 | N/A |
| 12/31/2013 | 438 | -54 | N/A | 9 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Er wordt voorspeld dat CCRN de komende 3 jaar winstgevend zal worden, wat wordt beschouwd als een snellere groei dan de spaarquote ( 2.6% ).
Winst versus markt: Er wordt verwacht dat CCRN de komende 3 jaar winstgevend zal worden. Dit wordt gezien als een groei die boven het gemiddelde van de markt ligt.
Hoge groeiwinsten: Er wordt verwacht dat CCRN binnen 3 jaar winstgevend zal worden.
Omzet versus markt: De omzet van CCRN zal naar verwachting de komende 3 jaar dalen ( -5.3% per jaar).
Hoge groei-inkomsten: De omzet van CCRN zal naar verwachting de komende 3 jaar dalen ( -5.3% per jaar).
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen CCRN zal naar verwachting over 3 jaar laag zijn ( 4.2 %).